Robert Nipper
Analyst · Raymond James
Yes. First, on tracer diagnostics. In the last call, we talked about the pricing pressure that we were seeing in the marketplace. It was twofold. One, the reduction in activity in the U.S. market as well as new competitors coming into the marketplace with tracer diagnostics. And there was a lot of pricing pressure and we were holding prices a little more firm than what our competitors were. And so it did cause a revenue reduction in the first quarter and as well as the fourth quarter from the previous year. So that has somewhat mitigated itself.We've made some adjustments in pricing, but we've also been able to go back to our customers and where they've had an opportunity to try new entrants into the market. Seeing what the quality was that they were actually getting, we've been able to win back some of that work.So in fact, recently, we've been -- a number of times, we've been completely sold out in terms of personnel being able to go on location. So we've seen that changing in the market. And some of the lower pricing that we believe was not sustainable, we're starting to see it wasn't sustainable, and those prices have slightly come up. So all those things together have combined in helping us to have a more clear view that tracer diagnostics is increasing in the U.S.Looking at the international business, on the last call, I mentioned that we were going to be down in revenue in the second quarter, but that we expected that we would have a pretty big jump in the second half of the year, and that's exactly what we're seeing now. And it is lumpiness in the international markets, but it's not unpredictable lumpiness, if you will.So what this was, it was a result, I mean, a big part of that increase is from the Aker BP contract that we've got in the North Sea. That project had stalled for a bit, with the intention of kicking back off in the third quarter, which we're actually seeing now. We already have shipped orders into Norway now to support that project, and we continue to see that business growing, as we thought that it would. But we've also been successful in getting some trial wells in the Mid East, which, as I'm sure you know, is pretty -- it can be a long protracted process to be able to even get those field trials.We've been successful in being able to make it a less long process, and we've had success in the field trial. So now we're starting to see the benefits of that. And so, there's been a lot of things that we've been doing over the last few quarters internationally, and it just takes time to build up over time. But I think we will see that the international business will continue to be lumpy, but we will see it -- the line will be moving up to the right.